MRD / Regn No. : 7051 Date : 06/07/2026
Patient Name : Sikha Halder Age & Gender : 48 Yrs. / Female
Contact No. : 9749857151 UHID :
Ht / Wt / BMI : 154 / 62 / 26.14 BP S / BP D : 148 / 86
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (02/Sep/2016) | HYPERTENSION (02/Sep/2022) |
Salient Investigations : HBA1C GLYCOSYLATED HEMOGLOBIN: 7.8 % | MICROALBUMIN CREATININE RATIO: 23.2 mcg/mg | NTPROBNP : 72
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET ROSUVASTATIN 10 MG
STATEZE R 		PO 0-0-1 BEFORE DINNER
2 ANTIHYPERGLYCEMIC GLICLAZIDE 60 MG + METFORMIN 500 MG
SECGLY M XR 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 TABLET DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
APDA L 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
4 TELMISARTAN 80 MG + CHLORTHALIDONE 12.5 MG
TAZLOC CT 80 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 06/Jan/2027
Tests Suggested For Next Visit : CHECK FPG, PPG AND BP AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: